Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Products

Free PSA

The Biorex Diagnostics Free Prostate Specific Antigen (PSA) CLIA kit is intended for the quantitative determination of free PSA concentration in human serum by a microplate chemiluminescence assay.

Prostate Specific antigen (PSA) is a serine protease with chymotrypsin-like activity. The protein is a single chain glycoprotein with a molecular weight of 28.4 kDA. PSA derives its name from the observation that it is a normal antigen of the prostate but is not found in any other normal or malignant tissue.

Add to Quote

Description

Product Name CAT.No Size
Free PSA BXL0861A 96T

 

 

Product Description

The Biorex Diagnostics Free PSA CLIA Kit is a quantitative chemiluminescent immunoassay (CLIA) designed for precise measurement of free prostate-specific antigen (PSA) in human serum. Free PSA represents the unbound fraction of total PSA, providing a more accurate assessment of prostate health and improving the differentiation between benign prostatic hyperplasia (BPH) and prostate malignancy. Accurate measurement of this biomarker is essential for early detection, risk stratification, therapy monitoring, and research applications.

This assay offers high sensitivity and specificity, ensuring reliable detection of physiologically and clinically relevant free PSA levels. The microplate CLIA format allows for high-throughput testing, enhancing laboratory efficiency and workflow. The kit includes ready-to-use reagents, calibrators, and controls, minimizing preparation errors and ensuring consistent results across multiple operators and laboratories.

Key Features

  • Quantitative CLIA Microplate Assay – precise measurement of free PSA concentrations.
  • High Sensitivity and Specificity – accurately detects clinically relevant levels for improved prostate assessment.
  • Reliable Reproducibility – ensures consistent results across multiple assays and laboratory settings.
  • Ready-to-Use Kit Components – includes reagents, standards, and controls for streamlined workflow.
  • Versatile Clinical and Research Utility – suitable for prostate cancer screening, differential diagnosis, risk assessment, and biomarker research.

Routine use of this kit enables clinicians to differentiate between benign and malignant prostate conditions, monitor patients undergoing therapy, and evaluate PSA kinetics for early detection of disease progression. In research, the assay provides essential data for studies on prostate physiology, cancer biomarkers, and endocrine regulation.

Designed for hospitals, clinical laboratories, and research facilities, the Biorex Diagnostics PSA CLIA Kit is a reliable, efficient, and user-friendly solution for quantitative PSA determination. Its reproducibility, sensitivity, and robust performance make it a critical tool for improving prostate health assessment, enabling timely clinical decisions, and supporting ongoing research in urology and oncology.

Contact Us for more information.

Additional information

Storage

2-8°C